FIELD: chemico-pharmaceutical industry.
SUBSTANCE: the present innovation deals with new stabilized pharmaceutical composition in its lyophilized form including the compound of formula I
as an active ingredient and lactose disaccharide as a stabilizing agent. The present pharmaceutical compositions are of high stability at storage. As for active ingredient it is not destroyed in the course of time.
EFFECT: higher efficiency.
10 cl, 15 ex, 6 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINED THERAPY INCLUDING SGLT INHIBITORS AND DPP4 INHIBITORS | 2009 |
|
RU2481106C2 |
| NEW POLYPEPTIDE COMPOUND | 1999 |
|
RU2219185C2 |
| MEDICINAL COMPOSITIONS | 1997 |
|
RU2197226C2 |
| METHOD FOR TREATMENT OF IMPAIRED GLUCOSE TOLERANCE | 2001 |
|
RU2281094C2 |
| PHARMACEUTICAL COMPOSITION | 1999 |
|
RU2203058C2 |
| APPLICATION OF BENZOPHENOL DERIVATIVE OR ITS SALT AND TNF-α INHIBITOR IN COMBINATION, AND PHARMACEUTICAL COMPOSITION, CONTAINING THEREOF OR ITS SALT AND INHIBITOR | 2009 |
|
RU2522272C2 |
| PHARMACEUTICAL COMPOSITION FOR PROPHYLAXIS, TREATMENT OR INHIBITION OF DEVELOPMENT OF SIMPLE RETINOPATHY AND PREPROLIFERATING RETINOPATHY | 2000 |
|
RU2239454C2 |
| APPLICATION OF THIAZOLIDINEDIONES FOR PREVENTION OR ONSET POSTPONEMENT OF INSULIN-INDEPENDENT DIABETES MELLITUS (NIDDM) | 1994 |
|
RU2195282C2 |
| PYRAZOLE[1,5-a]PYRIMIDINE DERIVATIVE | 2006 |
|
RU2390523C2 |
| 6,7-UNSATURATED 7-CARBAMOYL SUBSTITUTED MORPHINANDERIVATIVE | 2006 |
|
RU2403255C2 |
